Filing Details

Accession Number:
0001127602-12-014955
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-30 17:15:18
Reporting Period:
2012-04-26
Filing Date:
2012-04-30
Accepted Time:
2012-04-30 17:15:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236440 E Floyd Bloom Connaught House
1 Burlington Road
Dublin 4 Ireland
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-26 20,000 $17.59 90,281 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,028 Indirect Floyd E Bloom Charitable Remainder Trust
Common Stock 21,066 Indirect Jody Corey-Bloom Charitable Remainder Trust
Footnotes
  1. The reporting person's purchase of Alkermes plc ordinary shares reported herein was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was inadvertently effected one day prior to the expiry of the six-month holding period mandated under Section 16(b) of the Securities Exchange Act of 1934. This purchase is matchable to the reporting person's sale of the same number of shares on October 28, 2011. The reporting person and Alkermes plc have entered into an agreement under which the reporting person has paid Alkermes plc the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
  2. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.47 to $17.93. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.